Fitzsimons Innovation Community is an integrated urban campus where health and life sciences companies of all sizes work on their next big things. Our customized workspace, collaborative campus, and proximity to one of the top health systems and medical schools in the country make our community the perfect place to put down roots and get to work.
MOVE-IN READY LAB SPACE
GROWTH OPPORTUNITIES
It’s not just additional space—it’s fifty sprawling acres of additional space. And it’s primed for ultra-custom, made-to-order facility development.
Fitzsimons Innovation Community and University of Colorado Anschutz Medical Campus working together.
Relationships that help you thrive.
FEATURED:
Innovation does not stand still at Fitzsimons Innovation Community – and in 2025, the momentum was unmistakable. We are proud to announce the release of our 2025 Annual Innovation Report, a comprehensive look at the discoveries, partnerships, investments and infrastructure advancements shaping one of the nation’s most dynamic health innovation districts.
Fitzsimons Innovation Community is where innovators come to turn ideas into business.
A regular feature of a Fitzsimons Innovation Community visionary.
Our year in innovation.
Find out what’s happening on campus and across the industry.
An urban mountain lifestyle for work and play.
Everything you need.
Right here.
Read Fitzsimons Innovation Community news, industry highlights, editorials, and innovation updates happening weekly on our campus.
The Global Business Development division of the Colorado Office of Economic Development and International Trade (OEDIT) announced that 17 Colorado companies and eight researchers have been awarded Proof of Concept and Early-Stage Capital and Retention grants through OEDIT’s Advanced Industries Accelerator Program. Congratulations to the Fitzsimons Innovation Community Early-Stage Capital and Retention Grant Recipients: Onconaut Therapeutics, Inc., Vega Surgical, Inc., and Vona Oncology LLC.
UCHealth said it's the first in Colorado to offer a kind of mammogram that could be a game changer when it comes to detecting breast cancer. Dr. Elizabeth Vorhis, a breast radiologist said she uses an IV contrast during a mammogram. It's the same kind of process if you go to the emergency room and get a stomach or chest CT scan.
Colorado BioScience Association (CBSA) announced the winners of its 22nd Annual Awards Celebration, recognizing the people and organizations advancing Colorado’s position as a leading hub for health innovation. The awards spotlight leaders whose work accelerates breakthrough discoveries and delivers impact for patients in Colorado and around the world. Dr. Katherine Goodman, Associate Professor at the University of Colorado Denver | Anschutz, received the Educator of the Year Award for her outstanding contributions to shaping Colorado’s future life sciences workforce. EnteroTrack and RheumaGen were honored as Rising Star of the Year finalists.
Earlier this year, Kate Goes became the first patient in North America to use FDA-approved adaptive deep brain stimulation (DBS) technology for Parkinson’s. UCHealth Ph.D. clinical neuropsychologist John Thompson helped make the pathbreaking innovation possible.
Earlier this year, Kate Goes became the first patient in North America to use FDA-approved adaptive deep brain stimulation (DBS) technology for Parkinson’s. UCHealth Ph.D. clinical neuropsychologist John Thompson helped make the pathbreaking innovation possible.
Fitzsimons Innovation Community
